Clinical Trial Update: Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee [Phase 2]

View source ↗

Summary

Phase 2 study assessing the analgesic efficacy and safety of V116517 in adults with moderate to severe knee osteoarthritis pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• V116517

Snippet

Sponsor: Purdue Pharma LP | Conditions: Osteoarthritis, Knee, Pain | Phase 2 | Status: COMPLETED